Table 2.
Annual cost per patient with controlled hypertension (blood pressure brought below defined threshold) (2017 US$)
| Country income group | Country | Author | Intervention type | Sample size | Study design | Provider | Intervention details | Cost elements | Intervention subgroup | Cost (2017 US$) |
| Upper middle | Malaysia | Alefan | Pharm only | 600 | Observational | Doctors, nurses, pharmacists | Comparing different antihypertensive drug classes and combinations: Diuretics, BB, ACEIs, CCBs, prazosin, diuretics and ACEIs and other combinations | Drugs, laboratories, labour, and travel/transportation/per diem. | Diuretics | 626.78 |
| Beta blockers | 840.89 | |||||||||
| ACE Inhibitors | 977.54 | |||||||||
| Prazosin | 1004.07 | |||||||||
| Diuretics and beta blockers | 1172.96 | |||||||||
| Calcium channel blockers | 1446.8 | |||||||||
| Other combinations | 2509.7 | |||||||||
| Upper middle | Thailand | Pannarunothaai | Pharm only | 81 | Cross-sectional | Not specified | All cases of diabetes and hypertension that registered and made use of the urban health centre from 1994 to 1996 were included in group 1. All diabetic and hypertension patients who resided in the catchment area of the hospital, and visited the regional hospital from 1994 to 1996, were included in group 2. Group 3 included patients identified by the accidental sampling of diabetic and hypertension patients attending the regional hospital in 1997. | Drugs, cost of medical visit or screening - not further disaggregated, and travel/transportation/per diem. | Group 1 | 183.97 |
| Group 2 | 229.18 | |||||||||
| Group 3 | 231.05 |
ACEIs, ACE inhibitors; BB, beta blockers; CCBs, calcium channel blockers; US$, US dollars.